JIPMER Calls for proposals to Scientific Advisory Committee for March 2024, details

Published On 2024-02-09 04:00 GMT   |   Update On 2024-02-09 04:00 GMT
Advertisement

Puducherry- Through a notice, the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) has called for proposals to the JIPMER Scientific Advisory Committee (JSAC) for the month of March 2024.. The last date for submission of proposals (by mail and hard copy) is Monday, 19 February 2024.

On 7th March 2024, JIPMER is going to organise the 3rd meeting of the JIPMER Scientific Advisory Committee (JSAC).

Advertisement

Candidates are instructed to use the combined format containing Section-1 (for JSAC), and Section-2 (for Intramural Research Fund Committee) and fill both the sections accordingly. The Combine Format is available under the Research Category on the official website of JIPMER, which is mentioned in the notice.

The participants should ensure that they submit both an original hard copy and a Xerox copy of the research proposal, along with a cover letter addressed to the Dean (Research). The hard copy should be written in 11 font size, with 1.5 spacing and page numbering, using both sides of A4 size paper. If participants fail to submit the research proposal in the given format the proposal will not be accepted and no subsequent modification of the proposals will also not be accepted. Only citing and listing references as per the (International Committee of Medical Journal Editors (ICMJE) style will be accepted.

Candidates need to mail the soft copy of the proposal and Part-A General Information of the proposal in a Word file document. The candidates must ensure to keep their respective Head of Department in CC while sending the mail. The subject of the mail should be “Submission of proposal for the 3rd JSAC meeting in March 2024”.

The notice further stated that “There can be only one co-investigator from the same department to discourage gift co-investigatorship. It applies to both the department of primary investigator and the department of collaborating investigator”.

To view the official notice, click the link below-

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News